Company Information & Drug Savings for Corcept Therapeutics Medications
Corcept Therapeutics is a pharmaceutical company developing treatments for severe metabolic, oncologic, and psychiatric disorders by modulating cortisol activity. Based in Menlo Park, California, Corcept created Korlym (mifepristone), the first FDA-approved treatment for hyperglycemia in Cushing’s syndrome patients. The company’s cortisol modulator research targets endocrine disorders, depression, and cancer.
How to Contact Corcept Therapeutics
Phone
1-650-327-3270Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
